Inhibition of dapsone-induced methaemoglobinaemia in the rat
- 1 February 1990
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 39 (4) , 802-805
- https://doi.org/10.1016/0006-2952(90)90164-g
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.British Journal of Clinical Pharmacology, 1989
- AIDS‐related Pneumocystis carinii pneumonia successfully treated with dapsone‐trimethoprim [letter]British Journal of Clinical Pharmacology, 1988
- Clinical Pharmacokinetics of DapsoneClinical Pharmacokinetics, 1986
- Agranulocytosis associated with malaria prophylaxis with Maloprim.BMJ, 1983
- Leprosy TodayNew England Journal of Medicine, 1982
- In Vitro Inhibition of Granulopoiesis by 4‐Amino‐4′‐Hydroxylaminodiphenyl SulfoneBritish Journal of Haematology, 1980
- Sulfones and sulfonamides in dermatology todayJournal of the American Academy of Dermatology, 1979
- Microsomal N-Oxidation of Dapsone as a Cause of Methemoglobin Formation in Human Red Cells *The American Journal of Tropical Medicine and Hygiene, 1972
- Mechanism of methemoglobin formation by diphenylsulfones: Effect of 4-Amino-4′-hydroxyaminodiphenylsulfone and other p-substituted derivativesBiochemical Pharmacology, 1972
- The polymorphic acetylation of dapsone in manClinical Pharmacology & Therapeutics, 1971